Pioneering researchers at the intersection of artificial intelligence, computational biology, and drug discovery. Published at AAAI, NeurIPS, IROS, and Cell Reports Medicine.
Nearly five decades of combined experience across the world's leading technology companies and research institutions.
Nearly 5 decades of experience at the forefront of technology and innovation. Former EVP at META, with senior leadership roles at Microsoft, Samsung, and Oracle. Stanford affiliate researcher. Author of 20+ peer-reviewed papers spanning AI, computational biology, and multi-agent systems. Delivered an AAAI-26 oral presentation and serves as an IROS invited speaker. Active member of the Caltech-MIT Enterprise Forum. Creator of the Validated Accelerated Pipeline (VAP) and Automated Computational Hypothesis Testing (ACHT) frameworks that form the backbone of our platform.
Co-author of 23+ peer-reviewed papers in computational biology, AI drug discovery, and multi-agent systems. Deep expertise in multi-agent system architecture and the principal architect of the AI-Scientist v2 framework. Founder of Zytech Group, a renewable energy company, bringing a decade of experience in scaling technology ventures from concept to production. Bridges the gap between cutting-edge research and practical deployment, ensuring our computational tools deliver real-world results.
Our research team brings diverse expertise in computational chemistry, machine learning, and structural biology.
Advisory board members will be announced soon. We are assembling leaders in computational biology, drug development, and AI governance.
We are looking for exceptional researchers, engineers, and collaborators to join our mission of democratizing AI-powered drug discovery.